AMT protocol
Commercial- Indications
- Androgenetic alopecia, Sports injuries, Knee osteoarthritis
Company intelligence / Profile preview
Regenera Activa
Spainregeneraactiva.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Over 450,000 successful procedures performed worldwide, with more than 80 scientific publications supporting the technology's efficacy and safety[1][2][3]
- Therapeutic areas
- DermatologyRheumatology
- Modalities
- Autologous micrograftsRegenerative medicine
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
University of FlorenceUniversity of PaviaNATO (RAWINTS project)
Beyond the preview
Go deeper on Regenera Activa.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regenera Activa.